Strides Pharma Share Price: trides Pharma Science Ltd's (Strides) step‐down wholly-owned subsidiary received the approval for Levetiracetam Oral Solution USP, 100 mg/mL. Strides Pharma said it would manufacture the product at its facility in Bengaluru.
Stocks that were in focus included names like Strides Pharma, which fell 1.84%, Tata Steel, which rose 1.22%, and Sun TV, whose shares declined 1.28% on Tuesday.
As per Trendlyne data, the average target price of Strides Pharma is Rs 530, which shows a downside of 2% from the current market prices. The consensus recommendation from 3 analysts for the stock is a Buy .
Strides Pharma news: Strides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, received USFDA (United States Food and Drug Administration) approval for Icosapent Ethyl Capsules 0.5 gram and 1 gram. Get more Stocks News and Business News on Zee Business.
The announcement was made by the company ahead of the market closing. The stock settled at Rs 536 on the NSE, up Rs 37, or 7% over Friday s closing price. Strides Pharma Science shares also hit their 52-week high of Rs 539.